Li Wang

Li Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
WQWei Qin
Wei Qin
LWLi Wang
Li Wang
HTHuan Tian
Huan Tian
XWXiaocai Wu
Xiaocai Wu
CXCuicui Xiao
Cuicui Xiao
YYYang Yang
Yang Yang

1 December 2025 in Liver Research
Verified
Journal Article
Open access
CWChao Wang
Chao Wang
MFMingming Fan
Mingming Fan
JLJianrong Liu
Jianrong Liu
XGXiaolu Guo
Xiaolu Guo
ZTZhipeng Tan
Zhipeng Tan
QKQiong Ke
Qiong Ke
Adeno-associated virus (AAV) is becoming an attractive vector due to its low toxicity and minimal immunogenicity. However, liver-targeted AAV gene therapy still faces challenges, such as low delivery efficiency and safety risks associated with high vector doses. Isolated hepatic perfusion (IHP) has been explored as a localized drug delivery method, yet its full potential in gene therapy remains under investigation. Here, we investigated the efficiency of AAV8 delivery via the IHP route and its preference for hepatic transduction. The IHP route was established through surgery in rats and cynomolgus monkey, and the AAV8-dTomato solution was injected into the entire liver through the inflow tract and maintained for 10 min. One week later, liver tissues were obtained, and the dTomato fluorescence expression area fraction and intensity were analyzed. AAV8-dTomato delivery via the IHP resulted in over 60% dTomato-positive areas in rat liver and showed higher efficiency than the portal vein (PV) and inferior vena cava (IVC) routes at equivalent doses. In rats, AAV8-dTomato expression was primarily periportal across IHP, PV, and IVC routes, while in cynomolgus monkey, IHP delivery showed a pericentral pattern. In this study, we found that IHP is an effective strategy for AAV8 delivery. In addition, the distribution characteristics of AAV8, when delivered in cynomolgus monkey via IHP, provide candidate vector delivery schemes for gene therapy for different types of genetic liver diseases.

20 January 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QYQiWei Yang
QiWei Yang
THTao Huang
Tao Huang
HCHaoQi Chen
HaoQi Chen
XCXi Cao
Xi Cao
WZWenFeng Zhu
WenFeng Zhu
GWGenshu Wang
Genshu Wang